Radium-223 and concomitant therapies: prospects and prudence

Detalles Bibliográficos
Autores principales: Yeku, Oladapo, Slovin, Susan F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2016
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182218/
https://www.ncbi.nlm.nih.gov/pubmed/28078234
http://dx.doi.org/10.21037/tau.2016.11.04
_version_ 1782485826086633472
author Yeku, Oladapo
Slovin, Susan F.
author_facet Yeku, Oladapo
Slovin, Susan F.
author_sort Yeku, Oladapo
collection PubMed
description
format Online
Article
Text
id pubmed-5182218
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-51822182017-01-11 Radium-223 and concomitant therapies: prospects and prudence Yeku, Oladapo Slovin, Susan F. Transl Androl Urol Editorial AME Publishing Company 2016-12 /pmc/articles/PMC5182218/ /pubmed/28078234 http://dx.doi.org/10.21037/tau.2016.11.04 Text en 2016 Translational Andrology and Urology. All rights reserved.
spellingShingle Editorial
Yeku, Oladapo
Slovin, Susan F.
Radium-223 and concomitant therapies: prospects and prudence
title Radium-223 and concomitant therapies: prospects and prudence
title_full Radium-223 and concomitant therapies: prospects and prudence
title_fullStr Radium-223 and concomitant therapies: prospects and prudence
title_full_unstemmed Radium-223 and concomitant therapies: prospects and prudence
title_short Radium-223 and concomitant therapies: prospects and prudence
title_sort radium-223 and concomitant therapies: prospects and prudence
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182218/
https://www.ncbi.nlm.nih.gov/pubmed/28078234
http://dx.doi.org/10.21037/tau.2016.11.04
work_keys_str_mv AT yekuoladapo radium223andconcomitanttherapiesprospectsandprudence
AT slovinsusanf radium223andconcomitanttherapiesprospectsandprudence

Ejemplares similares